Differential Activation Of G-Protein Subtypes By Dopamine D1 Receptor Allosteric Modulation
Nguyen, A. M.; Umaoka, H.; Yano, H.
Show abstract
Allosteric modulation of G protein-coupled receptors (GPCR) is a rapidly advancing area of drug discovery with considerable therapeutic potential. In this study, we used various bioluminescence resonance energy transfer (BRET) assay configurations to investigate the differential activity of LY3154207, a dopamine D1 receptor (D1R)- positive allosteric modulator (PAM), in potentiating D1R-mediated signaling pathways. Our data showed that LY3154207 demonstrated clear bias toward {beta}-arrestin recruitment over G-protein engagement. Among the G-protein subtypes, LY3154207 preferentially potentiated Gs signaling induced by DA. Interestingly, when tested for its effect on the Gs-selective D1R agonist DHX and the Golf-selective agonist TAV, LY3154207 further enhanced the selectivity of these compounds, suggesting a probe-dependent effect. We also studied the structural mechanism underlying this subtype selectivity and found that W123 and R130 in the intracellular loop 2 (ICL2) of D1R were crucial for the activity of LY3154207. Furthermore, the N domain of the G-protein appeared to make minor contributions to this G-protein subtype selectivity of LY3154207. Lastly, our data demonstrated that LY3154207 induced cAMP production in the absence of the orthosteric ligand, indicating that this compound is an ago-PAM.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Design and validation of the first family of photo-activatable ligands for melatonin receptors 92%
- Development of potent and selective CK1α Molecular Glue Degraders 92%
- Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo Validation 92%
Similar papers in this journal
- A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptor 93%
- Structural Insights into Dopamine Receptor-Ligand Interactions: From Agonists to Antagonists 91%
- Exifone is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration 90%
Similar papers in this journal
- Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats 91%
- A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2 90%
- A selective adenylyl cyclase 1 inhibitor relieves pain without causing tolerance 90%
Similar papers in this journal
- A photoswitchable positive allosteric modulator to control the activation of the metabotropic glutamate receptor 5 by light 93%
- Design of peptide-based PAC1 antagonists combining molecular dynamics simulations and a biologically relevant cell-based assay 93%
- In silico screening of GMQ-like compounds reveals guanabenz and sephin1 as new allosteric modulators of acid-sensing ion channel 3 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.